Could This International ETF Be One of the Best Investments of 2026?

MSCI EAFE trades at just over 15x earnings versus the S&P 500 at ~23x, and EAFE yields ~3.4% versus ~1.5% for the S&P 500, indicating cheaper valuations and higher income abroad. Schwab International Equity ETF (SCHF) provides broad exposure with ~1,500 holdings, a largest position of 1.64%, an ultra-low expense ratio of 0.03% (~$3 per $10,000) and a ~3.2% dividend yield. Non-U.S. stocks outperformed the S&P 500 by more than 10 percentage points in 2025 and are outperforming in 2026, but investors should weigh currency and geopolitical headwinds and lower AI exposure when adding international allocations.

Analysis

The valuation gap between U.S. large caps and developed international markets is not just a multiple story — it’s a composition and flow story. U.S. indices concentrate rapidly appreciating secular winners (AI, cloud, software) while international indices retain higher shares of industrials, financials, and income-generating sectors; if investor flows rotate from growth to income/valuation, passive reallocation can create a multi-quarter rerating for international stocks even absent superior EPS growth.

Currency dynamics are the second-order lever that will amplify or mute any rerating. A stable-to-weaker dollar materially boosts reported USD returns for overseas earnings and can catalyze upside before fundamentals change; conversely, a renewed dollar rally or persistent hedging costs could erase much of the nominal multiple convergence, making FX management as important as security selection.

Sector-level winners will be selective: capital-intensive suppliers to global industrial recovery and dividend-heavy pharmaceutical/consumer staples names should capture both yield-seeking flows and defensive allocations, while pure-play AI/value chain beneficiaries remain underrepresented overseas — creating opportunities to layer targeted alpha via single-name exposure (ASML, AZN) rather than broad market beta alone. Key risks that reverse the move are geopolitics-led risk premia spikes and renewed US multiple expansion driven by another AI earnings surprise, both of which could compress international relative performance over 1–3 quarters.

Key Decisions for Investors

• Pair trade (6–12 months): Long SCHF (or equivalent developed ex-US ETF) 60% weight / Short SPY 40% weight to isolate relative valuation convergence. Objective: capture a 6–12% relative rerating if gap narrows; risk: US multiple re-expands or USD strength. Use a 6% portfolio stop-loss or hedge with 3-month SPY calls to limit tail risk.
• Conviction long single-name (9–18 months): Buy ASML (or 12–18 month LEAPS call spread) to capture secular lithography exposure outside US-dominated cloud capex. Reward: asymmetric re-rating if equipment cycle accelerates; Risk: China capex pullback or export controls. Size to 1–2% portfolio, sell 25% into +20% move, cut at -15%.
• Income + defensive tilt (6–12 months): Buy AZN (1–2% portfolio) for higher cash return and lower sensitivity to AI-driven multiple moves; pair with short cyclicals in same market (e.g., European small-cap cyclicals) to reduce macro beta. Target: 6–10% total return with lower volatility; stop-loss -12%.
• FX-managed overlay (3–9 months): If initiating overseas exposure, buy EURUSD call spread or purchase short-dated forward buys to hedge the USD-depreciation tail rather than leave exposure unhedged. Pay ~20–50bp equivalent premium to avoid a USD-strength drawdown that could erase equity gains; allocate hedging cost to risk budget rather than P&L surprise.